Loading company…
Mirrx Therapeutics is developing a microRNA-blocking technology.
Mirrx Therapeutics is developing a microRNA-blocking technology. The company is based in Lyngby, Denmark.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in